Do analysts recommend SHPH or AEYE?

Audioeye has a consensus target price of $14.63, suggesting a potential upside of 115.71%. Given Audioeye's stronger consensus rating and higher possible upside, analysts clearly believe Audioeye is more favorable than Shuttle Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Audioeye 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts rate MWC or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Micware 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, MWC or SHPH?

Micware has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Micware $140.31M 0.70 $10.27M N/A N/A Shuttle Pharmaceuticals N/A N/A -$11.72M -$18.64 N/A

Is MWC or SHPH more profitable?

Micware's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Micware N/A N/A N/A Shuttle Pharmaceuticals N/A -168.34% -90.59%

Do analysts prefer CMCM or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cheetah Mobile 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend NTWK or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NetSol Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer AISP or SHPH?

Airship AI presently has a consensus target price of $6.50, indicating a potential upside of 209.52%. Given Airship AI's stronger consensus rating and higher probable upside, research analysts plainly believe Airship AI is more favorable than Shuttle Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Airship AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Shuttle Pharmaceuticals (SHPH) Competitors

$5.52 +0.28 (+5.34%)

As of 01:56 PM Eastern

Compare

SHPH vs. AEYE, MWC, CMCM, NTWK, and AISP

Should you buy Shuttle Pharmaceuticals stock or one of its competitors? Shuttle Pharmaceuticals's main competitors and comparable companies include Audioeye (AEYE), Micware (MWC), Cheetah Mobile (CMCM), NetSol Technologies (NTWK), and Airship AI (AISP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Shuttle Pharmaceuticals compare to Audioeye?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Audioeye (NASDAQ:AEYE) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Audioeye had 2 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 3 mentions for Audioeye and 1 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 1.79 beat Audioeye's score of 0.45 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Very Positive
Audioeye	Neutral

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Audioeye's net margin of -10.92%. Audioeye's return on equity of 121.59% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-168.34%	-90.59%
Audioeye	-10.92%	121.59%	15.45%

Audioeye has a consensus target price of $14.63, suggesting a potential upside of 115.71%. Given Audioeye's stronger consensus rating and higher possible upside, analysts clearly believe Audioeye is more favorable than Shuttle Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Audioeye	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 51.1% of Audioeye shares are owned by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are owned by company insiders. Comparatively, 25.9% of Audioeye shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Shuttle Pharmaceuticals has a beta of 0.11, indicating that its share price is 89% less volatile than the broader market. Comparatively, Audioeye has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Audioeye has higher revenue and earnings than Shuttle Pharmaceuticals. Audioeye is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$18.64	N/A
Audioeye	$40.31M	2.11	-$3.08M	-$0.36	N/A

Summary

Audioeye beats Shuttle Pharmaceuticals on 12 of the 15 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Micware?

Micware (NASDAQ:MWC) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Micware has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Micware	$140.31M	0.70	$10.27M	N/A	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$18.64	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Micware	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Micware had 1 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 2 mentions for Micware and 1 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 1.79 beat Micware's score of 1.39 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Micware	Positive
Shuttle Pharmaceuticals	Very Positive

Micware's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Micware	N/A	N/A	N/A
Shuttle Pharmaceuticals	N/A	-168.34%	-90.59%

Summary

Micware beats Shuttle Pharmaceuticals on 5 of the 8 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Cheetah Mobile?

Cheetah Mobile (NYSE:CMCM) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

Shuttle Pharmaceuticals has lower revenue, but higher earnings than Cheetah Mobile. Cheetah Mobile is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cheetah Mobile	$1.12B	0.06	-$36.85M	-$1.51	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$18.64	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cheetah Mobile	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cheetah Mobile has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.11, meaning that its share price is 89% less volatile than the broader market.

In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than Cheetah Mobile. MarketBeat recorded 1 mentions for Shuttle Pharmaceuticals and 0 mentions for Cheetah Mobile. Shuttle Pharmaceuticals' average media sentiment score of 1.79 beat Cheetah Mobile's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Cheetah Mobile	Neutral
Shuttle Pharmaceuticals	Very Positive

0.4% of Cheetah Mobile shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 17.1% of Cheetah Mobile shares are owned by company insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Cheetah Mobile's net margin of -28.11%. Cheetah Mobile's return on equity of -8.54% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cheetah Mobile	-28.11%	-8.54%	-3.22%
Shuttle Pharmaceuticals	N/A	-168.34%	-90.59%

Summary

Cheetah Mobile and Shuttle Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to NetSol Technologies?

NetSol Technologies (NASDAQ:NTWK) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NetSol Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NetSol Technologies has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market.

NetSol Technologies has higher revenue and earnings than Shuttle Pharmaceuticals. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than NetSol Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NetSol Technologies	$74.40M	1.04	$2.95M	$0.25	25.96
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$18.64	N/A

16.0% of NetSol Technologies shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 13.5% of NetSol Technologies shares are owned by insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, NetSol Technologies had 2 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 3 mentions for NetSol Technologies and 1 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 1.79 beat NetSol Technologies' score of 0.68 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
NetSol Technologies	Positive
Shuttle Pharmaceuticals	Very Positive

NetSol Technologies has a net margin of 4.02% compared to Shuttle Pharmaceuticals' net margin of 0.00%. NetSol Technologies' return on equity of 6.79% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NetSol Technologies	4.02%	6.79%	4.35%
Shuttle Pharmaceuticals	N/A	-168.34%	-90.59%

Summary

NetSol Technologies beats Shuttle Pharmaceuticals on 12 of the 13 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Airship AI?

Airship AI (NASDAQ:AISP) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Airship AI presently has a consensus target price of $6.50, indicating a potential upside of 209.52%. Given Airship AI's stronger consensus rating and higher probable upside, research analysts plainly believe Airship AI is more favorable than Shuttle Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Airship AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Airship AI has higher revenue and earnings than Shuttle Pharmaceuticals. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Airship AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Airship AI	$18.15M	3.99	$29.32M	$0.67	3.13
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$18.64	N/A

In the previous week, Airship AI had 1 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 2 mentions for Airship AI and 1 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 1.79 beat Airship AI's score of 0.89 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Airship AI	Positive
Shuttle Pharmaceuticals	Very Positive

Airship AI has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market.

5.9% of Airship AI shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 46.8% of Airship AI shares are held by company insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Airship AI has a net margin of 144.60% compared to Shuttle Pharmaceuticals' net margin of 0.00%. Airship AI's return on equity of -19.13% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Airship AI	144.60%	-19.13%	18.72%
Shuttle Pharmaceuticals	N/A	-168.34%	-90.59%

Summary

Airship AI beats Shuttle Pharmaceuticals on 13 of the 14 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHPH vs. The Competition

Export

Metric	Shuttle Pharmaceuticals	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$26.28M	$16.64B	$29.75B	$12.86B
Dividend Yield	N/A	3.42%	2.76%	19.59%
P/E Ratio	-0.30	143.49	78.24	25.24
Price / Sales	N/A	1,269.75	576.54	75.12
Price / Cash	N/A	46.54	49.01	52.75
Price / Book	0.50	8.84	7.68	5.99
Net Income	-$11.72M	$429.53M	$767.06M	$380.69M
7 Day Performance	-0.54%	-1.03%	-3.86%	-3.48%
1 Month Performance	56.37%	-1.13%	-3.11%	-6.02%
1 Year Performance	-85.66%	-0.15%	160.65%	-5.75%

Shuttle Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHPH Shuttle Pharmaceuticals	0.9327 of 5 stars	$5.52 +5.3%	N/A	-86.6%	$26.28M	N/A	N/A	2	Positive News Analyst Upgrade
AEYE Audioeye	3.885 of 5 stars	$6.95 +0.4%	$14.63 +110.4%	-51.9%	$87.36M	$40.31M	N/A	116
MWC Micware	N/A	$1.47 -3.6%	N/A	N/A	$87.35M	$140.31M	N/A	483	Positive News
CMCM Cheetah Mobile	0.268 of 5 stars	$2.53 +0.4%	N/A	-69.9%	$76.71M	$164.51M	N/A	851	Gap Down
NTWK NetSol Technologies	1.5349 of 5 stars	$6.26 +1.5%	N/A	+44.2%	$74.81M	$74.40M	25.04	1,370	Analyst Upgrade Short Interest Increase High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHPH) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. AEYE, MWC, CMCM, NTWK, and AISP

How does Shuttle Pharmaceuticals compare to Audioeye?

Summary

How does Shuttle Pharmaceuticals compare to Micware?

Summary

How does Shuttle Pharmaceuticals compare to Cheetah Mobile?

Summary

How does Shuttle Pharmaceuticals compare to NetSol Technologies?

Summary

How does Shuttle Pharmaceuticals compare to Airship AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. AEYE, MWC, CMCM, NTWK, and AISP

How does Shuttle Pharmaceuticals compare to Audioeye?

Does the media prefer SHPH or AEYE?

Is SHPH or AEYE more profitable?

Do analysts recommend SHPH or AEYE?

Do insiders & institutionals hold more shares of SHPH or AEYE?

Which has more risk and volatility, SHPH or AEYE?

Which has higher earnings & valuation, SHPH or AEYE?

Summary

How does Shuttle Pharmaceuticals compare to Micware?

Do insiders & institutionals have more ownership in MWC or SHPH?

Which has higher valuation and earnings, MWC or SHPH?

Do analysts rate MWC or SHPH?

Does the media favor MWC or SHPH?

Is MWC or SHPH more profitable?

Summary

How does Shuttle Pharmaceuticals compare to Cheetah Mobile?

Which has better earnings and valuation, CMCM or SHPH?

Do analysts prefer CMCM or SHPH?

Which has more volatility & risk, CMCM or SHPH?

Does the media prefer CMCM or SHPH?

Do insiders & institutionals believe in CMCM or SHPH?

Is CMCM or SHPH more profitable?

Summary

How does Shuttle Pharmaceuticals compare to NetSol Technologies?

Do analysts recommend NTWK or SHPH?

Which has more volatility & risk, NTWK or SHPH?

Which has better valuation & earnings, NTWK or SHPH?

Do insiders and institutionals believe in NTWK or SHPH?

Does the media prefer NTWK or SHPH?

Is NTWK or SHPH more profitable?

Summary

How does Shuttle Pharmaceuticals compare to Airship AI?

Do analysts prefer AISP or SHPH?

Which has preferable earnings & valuation, AISP or SHPH?

Does the media favor AISP or SHPH?

Which has more risk & volatility, AISP or SHPH?

Do insiders & institutionals believe in AISP or SHPH?

Is AISP or SHPH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools